$AVXL

Anavex Life Sciences Corporation

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$17.98 ▲5.578%

Last Close

VOLUME

964,813

DAY RANGE

16.7 - 18.1705

52 WEEK

4.51 - 31.5

Join Discuss about AVXL with like-minded investors

profile
@dros #droscrew
recently

+Initiations 9/23: $ANXX $AOSL $AVDL $AVXL $BIIB $BTBT $DNMR $FSR $GTLS $HRMY $ITCI $JAZZ $JOBY $KNTE $LABP $LIDR $MCG $MRTX $OVV $OXLC $PCT $RBC $RPD $RPTX $SAGE $SFET $SITC $SWBK $UE $XFLT . -Initiations 9/23: $TSLA

60 Replies 7 👍 11 🔥

profile
@dros #droscrew
recently

RECAP 8/31 Chatter: $AVXL + Alzheimer's patent $VG + Jana advocates sale/break up $DIS + Star+ latin america $ELYS + DC Betting $WFC - Regulatory action $CNI+ $KSU CP - STB Rejects voting trust

121 Replies 8 👍 12 🔥

profile
@cespinoza9801 #ivtrades
recently

$avxl 🚀🚀🚀 amazing trade

131 Replies 9 👍 7 🔥

TR
@TraderJack #ivtrades
recently

$AVXL launchpad...."How is the weather there"...."SIr, Getting Better"....."OK, Make sure everything ready"....."Yes, Sir"........

141 Replies 7 👍 14 🔥

TR
@TraderJack #ivtrades
recently

$AVIR still in the journey to the Mars.....$AVXL sits on launch pad and waiting for good weather......forget all about these just my pumping........

71 Replies 14 👍 7 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, August 12, 2021 Futures Up/Down % Last Dow 40.00 0.12% 35,413 S&P 500 2.25 0.05% 4,442 Nasdaq 5.50 0.04% 15,025 Another day, another record high for the Dow and S&P 500 as futures are pointing to a slightly higher open, building on the ongoing upside momentum that pushed the S&P 500 to its 45th all-time high Wednesday. Both the Dow Jones Industrial Average and S&P 500 are coming off all-time bests as consumer prices (CPI) data indicated U.S. inflation was in-line with estimates, raising hopes that growth may have peaked, while sectors tied to economic growth such as industrials, materials and metals advanced a second day on the heels of the passage of a large infrastructure bill. The July consumer price index increased 0.5% last month after climbing 0.9% in June, though on a YoY basis was above 5% again (ahead of today’s PPI data at 8:30 AM ET). Meanwhile, two Fed members (George and Kaplan) each said the central bank should announce its timeline to reduce its massive bondholding, with Kaplan calling for it to begin next month, with tapering to begin in October. Healthcare was also a drag on markets as S&P components MRNA and PFE fell after the drug regulator of the European Union said it was looking into new possible side-effects of mRNA COVID-19 shots. Asian shares dropped for the first time this week as China stepped up scrutiny of its insurance technology platforms while European stocks drift on mixed earnings results. The Nikkei Index slipped -55 points to 28,015, the Shanghai Index slid -7 points to 3,524, and the Hang Seng Index dropped -142 points (0.535) to settle at 26,517. In Europe, the German DAX is up over 60 points to 15,888, while the FTSE 100 is down a few points at 7,210. Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 375K 8:30 AM EST Continuing Claims…est. 2.88M 8:30 AM ET Producer Price Index (PPI) MoM for July…est. 0.6% 8:30 AM ET PPI Ex: Food & Energy (core) MoM for July…est. 0.5% 8:30 AM ET Producer Price Index (PPI) YoY for July…est. 7.3% 8:30 AM ET PPI Ex: Food & Energy (core) YoY for July…est. 5.6% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 1:00 PM ET U.S. to sell $27 bln in 30-year bonds Earnings Calendar: Earnings Before the Open: AVXL, AZEK, BDR, BODY, BR, BTTR, CELH, EFOI, EMAN, EYE, FSTX, GRWG, HOOK, KELYA, MDP, MIDD, MKTW, NYC, PGTI, SOHO, TAST, UP, UTZ, VERU Earnings After the Close: ABNB, ACHV, AFIB, APDN, ASTR, AWH, BBI, BIOL, BLBD, BOXL, BW, CAPR, CODX, CRMD, DASH, DCO, DIS, EAR, FIGS, FLO, FRGI, HOFV, ICCC, INTZ, IPWR, KINS, LAZR, LIVX, LMB, LVOX, LZ, MOTS, OPGN, PHUN, PTE, SFE, SGHT, SOFI, TLMD, TPCS, VIVE, WISH, XL Other Key Events: BTIG HIMSS Digital Health Booth Tour (virtual), 8/11-8/12 Canaccord Genuity 41st Annual Growth Conference (virtual), 8/10-8/12 Cowen Annual Communications Infrastructure Hybrid Summit, 8/9-8/12 Cowen 9th Annual Internet & Media Bus Tour (virtual), 8/9-8/13 Credit Suisse 4th Annual FinTech Conference (virtual), 8/11-8/13 JPMorgan Auto Conference (virtual), 8/11-8/12 KeyBanc Capital Markets Technology Leadership Virtual Forum, 8/9-8/12 Oppenheimer 24th Annual Technology, Internet & Comm Conference (virtual), 8/10-8/12 Piper Biotech Virtual Tour, 8/10-8/12 UBS Financial Services Conference (virtual), 8/10-8/12 Market Closing Prices Yesterday The S&P 500 Index gained 10.95 points, or 0.25%, to 4,447.70 The Dow Jones Industrial Average rose 220.30 points, or 0.62%, to 35,484.97 The Nasdaq Composite slipped -22.95 points, or 0.16%, to 14,765.14 The Russell 2000 Index advanced 10.98 points, or 0.49% to 2,250.34 Macro Up/Down Last Nymex -0.08 69.17 Brent -0.04 71.40 Gold 1.10 1,752.80 EUR/USD -0.0002 1.1737 JPY/USD -0.02 110.41 10-Year Note -0.008 1.351% World News The International Energy Agency (IEA) cut its outlook for global oil demand “sharply” for the rest of 2021 as the resurgence of coronavirus rocks major consumers and predicted a new surplus in 2022. The IEA cut its 2021 global oil demand growth forecast by 100,000 barrels a day, while upgrading its 2022 forecast by 200,000 barrels a day Eurozone Jun Industrial Production: m/m -0.3% vs -0.2% consensus; y/y 9.7% vs 10.4% consensus UK Q2 GDP: q/q 4.8% in-line; y/y 22.2% vs 22.1% consensus; UK Jun GDP: 1.0% vs 0.8% consensus; UK June Trade Balance: -£11.99b vs -£9.1b consensus; K June Ind Production m/m 0.7% vs 0.3% consensus, y/y 8.3% vs 9.4% consensus Sector News Breakdown Consumer DoorDash ($DASH) is said to have held talks to purchase Instacart over the past two months that may have valued the grocery delivery company at $40B to $50B. The talks felt apart in recent weeks at least partly over regulatory concerns, according to a report in The Information https://bit.ly/2VKi4F5 Core-Mark Holding ($CORE) said the waiting period under the HSR act for Performance Food Group’s (PFGC) planned purchased expired on Aug. 9 and the closing conditions for the deal have been satisfied Fisker Inc ($FSR) announces private offering of $600 mln 5-yr convertible notes Nio ($NIO) Q2 non-GAAP EPS loss (-$0.03) vs. est. loss (-$0.11); Revenue of $1.31B (+127% Y/Y) beats by $20M; said achieved a record-high quarterly delivery of 21,896 vehicles in Q2, followed by 7,931 vehicles in July, bringing the cumulative deliveries of NIO vehicles to 125,528 as of July 31, 2021 Blink Charging ($BLNK) 2Q EPS ($0.32) vs est. ($0.16) on revs $4.4Mm vs est. $2.6Mm eBay Inc. ($EBAY) Q2 adj EPS $0.99 vs. est. $0.95; Q2 revs $2.7B vs. est. $3.00B; expands share repurchase authorization by an additional $3B; entered agreement to sell about 135M shares of eBay’s Adevinta stock to Permira for over $2.4B, reducing ownership to 33%; announced an agreement to sell 80.01% of eBay Korea business to eMart for about $3B; guides Q3 revs $2.42B-$2.47B vs. est. $2.92B; annual active sellers grew by 5%, for total of 19M global active sellers Fossil Group ($FOSL) 2Q EPS ($0.02) on sales $411Mm; sees 3Q net sales +5-10%; guides FY net sales growth to approx +14-17%; Lordstown Motors ($RIDE) 2Q EPS ($0.61) vs est. ($0.49); pursuing external capital sources including debt and equity-linked securities; sees FY op exp $95-105Mm, expects to end 3Q with liquidity between 225-275Mm cash and equivalents without any funds from a capital raise Utz Brands ($UTZ) Q2 adj EPS 13c vs. est. 15c; Q2 revs $299.2M vs. est. $290.29M; sees FY 2021 adjusted shr $0.55 to $0.60; believes that consumer demand for its products will remain strong in second half of fiscal 2021; says continue to expect fiscal 2021 net sales consistent with fiscal 2020 pro forma net sales Vroom ($VRM) Q2 adj EPS loss (-$0.48), in-line with consensus; Q2 revs $761.89M vs. est. $637.99M; for Q2, had18,268 ecommerce units sold, up 172% YoY; Ecommerce revenue of $579.7 million, up 230% YoY; Ecommerce gross profit of $49.6 million, up 588% YoY Energy Array Technologies ($ARRY) 2Q EPS $0.00 vs est. $0.01 on revs $202.8Mm vs est. $231Mm; guides FY revs $850-940Mm vs est. $1B, sees FY adj EPS $0.15-0.25 vs est. $0.37 EnerSys ($ENS) Q adj EPS $1.25 vs est. $1.20 on revs $814.9Mm vs est. $810.5Mm, backlog grew $157Mm; guides 2Q adj EPS $1.03-1.13 vs est. $1.28 Canadian Solar ($CSIQ) Q2 EPS $0.18 vs. est. loss (-$0.30); Q2 revs $1.43B vs. est. $1.43B; Q2 solar module shipments of 3.7 GW, top end of 3.5 GW to 3.7 GW guidance; sees Q3 revs $1.2B-$1.4B vs. est. $1.62B; reducing its full year 2021 total module shipment guidance to 16 GW to 17 GW; reiterates its project sales guidance and total battery storage shipment guidance for FY 2021; carve-out IPO of CSI solar subsidiary remains on track Financials AllianceBernstein L.P. ($AB) preliminary assets under management increased to $748 billion during July 2021 from $738 billion at the end of June. Market appreciation and modest firmwide net inflows drove the 1% increase. Manning & Napier, Inc. ($MN) reported preliminary assets under management (“AUM”) as of July 31, 2021 of $22.5 billion, compared with $22.3 billion at June 30, 2021 Victory Capital Holdings, Inc. ($VCTR) reported assets under management (AUM) of $162.9 billion as of July 31, 2021. Opendoor Technologies (OPEN) Q2 EPS loss (-$0.24) vs. est. loss (-$0.34); Q2 revs $1.2B vs. est. $1.09B; Gross profit of $159 million, up 64% versus 1Q21; gross margin of 13.4%, up 40 basis points versus 1Q21; Adjusted EBITDA of $26 million versus ($2) million in 1Q21; adjusted EBITDA margin of 2.2% versus (0.3%) in 1Q21; sees Q3 revenue $1.8B-$1.9B vs. est. $1.52B Healthcare In vaccine news, NBC reports that the FDA would authorize a third shot of coronavirus vaccine as soon as Thursday for certain people with weakened immune systems. The decision to expand the emergency use of the vaccines from Moderna ($MRNA) and the Pfizer ($PFE)/BioNTech ($BNTX) shots Amwell ($AMWL) Q2 EPS loss (-$0.15) vs. est. loss (-$0.19); Q2 revs $60.2M vs. est. $61.7M; Q2 gross margins increased 600 bps to 44% of revenue versus 38% last quarter; said total visits of 1.3 million versus 1.6 million last quarter; lowers year revs to $252M-$262M from $260M-$270M and narrows year adj Ebitda loss view Fulcrum Therapeutics ($FULC)6M share secondary priced at $19.00 GoHealth ($GOCO) 2Q EPS ($0.12) vs est. ($0.04) on revs $196.9Mm vs est. $175.1Mm; guides FY revs $1.2-1.3B vs est. $1.24B, sees FY adj EBITDA $300-330Mm Hims & Hers ($HIMS) Q2 EPS loss (-$0.05) vs. est. loss (-$0.10); Q2 revs $60.7M vs. est. $56.49M; sees Q3 revs $69M-$71M vs. est. $58.31M and sees year revs $251M-$255M vs. est. $226.3M Xeris Pharmaceuticals ($XERS) announced it has received U.S. FDA clearance for phase 1 clinical trials for its hypothyroidism treatment Industrials & Materials Apogee Enterprises ($APOG) announced plans to realign and simplify its business structure to “bring a stronger focus to serving customers, enable a more competitive cost model, and better position the company for future growth and improved profitability; now expects to achieve $20M-$30M of annualized savings by the end of fiscal 2023 Royal Gold ($RGLD) 4Q EPS $1.25 vs est. $0.92 on revs $168Mm vs est. $165Mm; guides 1Q stream segment sales 62,000-67,000 GEOs with qtr-end inventory 22,000-27,000 GEOs Gates Industrial ($GTES) 25M share Secondary priced at $16.00

128 Replies 8 👍 8 🔥

profile
@cespinoza9801 #ivtrades
recently

I'm in $avxl nice setup

95 Replies 6 👍 15 🔥

TR
@TraderJack #ivtrades
recently

$AVXL is still target for the moon.......chief engineer told me that they prepare to launch it again.........

73 Replies 14 👍 15 🔥

profile
@thegiz18 #ivtrades
recently

$AVXL failure to launch, rescheduled for another day

64 Replies 6 👍 7 🔥

TR
@TraderJack #ivtrades
recently

Maybe today is the day for $AVXL launch to the moon.......hope the weather corporates.......

95 Replies 11 👍 10 🔥

TR
@TraderJack #ivtrades
recently

$AVXL sitiing on the lauchpad and waiting.......

118 Replies 6 👍 10 🔥

TR
@TraderJack #ivtrades
recently

Hope weather cooperate, $AVXL is sitting on launchpad and waiting.........

45 Replies 10 👍 9 🔥

TR
@TraderJack #ivtrades
recently

$AVXL is still waiting for launch into space......chief engineer told me the goal is to reach the moon.........

53 Replies 6 👍 14 🔥

TR
@TraderJack #ivtrades
recently

The weather condition is getting better....the launch time for $AVXL is near..........

100 Replies 12 👍 7 🔥

TR
@TraderJack #ivtrades
recently

$AVXL is ready to launch and just waiting for weather clear out..........

96 Replies 15 👍 15 🔥

TR
@TraderJack #ivtrades
recently

Chief engineer told me the market meltdown drag/delay the launch of $AVXL and $AVIR space trip.......

67 Replies 7 👍 13 🔥

TR
@TraderJack #ivtrades
recently

Chief engineer told me that $AVXL is ready on launchpad for another moon trip.......

88 Replies 9 👍 13 🔥

profile
@EricV #ivtrades
recently

need a ride from Bezo > @TraderJack said: $AVXL may visit the moon again..........

113 Replies 10 👍 7 🔥

TR
@TraderJack #ivtrades
recently

$AVXL may visit the moon again..........

123 Replies 8 👍 14 🔥

profile
@EricV #ivtrades
recently

$AVXL is free fall today

40 Replies 8 👍 12 🔥

profile
@thegiz18 #ivtrades
recently

You nailed $AVXL Jackie

80 Replies 15 👍 9 🔥

TR
@TraderJack #ivtrades
recently

$AVXL go to the moon ......

48 Replies 8 👍 13 🔥

ST
@stevengo #StockTraders.NET
recently

I did, in my mind. I'm a Billionare up there. > @maletone said: who ever shorted $AVXL salute to you

120 Replies 12 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

who ever shorted $AVXL salute to you

136 Replies 6 👍 13 🔥

BR
@BrittJ #StockTraders.NET
recently

$AVXL at 25

93 Replies 12 👍 6 🔥

BR
@BrittJ #StockTraders.NET
recently

$AVXL ss at 24.7

72 Replies 9 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$AVXL almost back to $25's

55 Replies 10 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

slow day was down a coupld grand and now about flatish as soon as I cover this $AVXL

50 Replies 13 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

$AVXL losing it

98 Replies 6 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

stopped on $AVXL

70 Replies 11 👍 6 🔥

TR
@TraderJack #ivtrades
recently

$AVXL to the moon...........

84 Replies 9 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

$AVXL working though

57 Replies 9 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

watchlist: $Mnov, $AVXL, $GERN,

114 Replies 14 👍 15 🔥

TR
@TraderJack #ivtrades
recently

haha, $AVXL........

81 Replies 13 👍 15 🔥

TR
@TraderJack #ivtrades
recently

Down market do not going to stop $AVXL going to moon..........

98 Replies 13 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

watch for tomorrow: $MTP, $TRCH, $TIGR, $AVXL

73 Replies 15 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

should have shorted $AVXL I was hoping for higher it basically a failed break out

51 Replies 9 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$avxl breaking out

126 Replies 15 👍 11 🔥

TR
@TraderJack #ivtrades
recently

$AVXL on the way to moon........

48 Replies 11 👍 11 🔥

TR
@TraderJack #ivtrades
recently

Kaboo, $AVXL.....

102 Replies 6 👍 11 🔥

TR
@TraderJack #ivtrades
recently

$AVXL go to moon with Jeff Bezos and his brother.........

89 Replies 7 👍 8 🔥

TR
@TraderJack #ivtrades
recently

$AVXL go to moon......

52 Replies 14 👍 11 🔥

TR
@TraderJack #ivtrades
recently

$AVXL to $40.....Bought at $5 long time ago......

102 Replies 9 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$avxl is setting up

104 Replies 7 👍 15 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Monday June 07, 2021 = =============================================*/ Monday, June 7, 2021 Futures Up/Down % Last Dow 30.00 0.09% 34,772 S&P 500 -4.25 0.10% 4,224 Nasdaq -45.50 0.33% 13,721 U.S. futures are mixed to start the trading week as the Dow rises, S&P little changed and Nasdaq futures slide about 45 points as shares of U.S. tech giants decline after the Group of Seven (G7) advanced economies agreed this weekend to back a minimum global tax rate of at least 15% (watch shares of $AAPL, $AMZN, $FB, $GOOGL). Apple (AAPL) will kick off its annual Worldwide Developer Conference at 1 p.m. ET. In healthcare, all eyes on Biogen ($BIIB) as the company rises ahead of FDA decision on Alzheimer’s drug aducanumab as the FDA is set to decide on whether to approve company’s controversial Alzheimer’s disease drug. This weekend, Treasury Secretary Janet Yellen said President Joe Biden should push forward with his $4 trillion spending plans even if they cause an inflation spike into next year. She also told Bloomberg in an interview that slightly higher interest rates would be a plus. Other than that, a quiet day for economic data. Stocks climbed on Friday as the key May jobs report showed solid gains, boosting confidence in the economic comeback, while for the week, the S&P rose 0.62%, the Dow added 0.66%, the Nasdaq gained 0.48%. Bitcoin and most other top cryptocurrencies fell on Sunday on concerns that there may be a further crackdown on the industry in China and as a report from Goldman Sachs Group Inc. served as a reminder that institutional adoption may be a long process. In Asian markets, The Nikkei Index rose 77 points to settle at 29,020, the Shanghai Index rose 7 points to 3,599, and the Hang Seng Index slipped -130 points to 28,787. In Europe, the German DAX is up about 35 points to 15,725, while the FTSE 100 is up around 20 points to 7,090. Market Closing Prices Yesterday The S&P 500 Index jumped 37.04 points, or 0.88%, to 4,229.89 The Dow Jones Industrial Average rose 179.39 points, or 0.52%, to 34,756.39 The Nasdaq Composite surged 199.99 points, or 1.47%, to 13,814.49 The Russell 2000 Index advanced 7.16 points, or 0.31% to 2,286.41 Events Calendar for Today 3:00 PM EST Consumer Credit for April Earnings Calendar: Earnings Before the Open: $GII Earnings After the Close: $BBCP, $COUP, $HQY, $MRVL, $MTN, $NAPA, $REVG, $SFIX Other Key Events: American Society of Clinical Oncology (ASCO), 6/4-6/8 Deutsche Bank Global Consumer Conference (virtual), 6/7-6/10 Goldman Sachs Travel & Leisure Conference 2021 (virtual), 6/7-6/8 Oppenheimer Virtual Software & Semiconductor Bus Tour, 6/7-6/11 Macro Up/Down Last Nymex -0.39 69.23 Brent -0.43 71.46 Gold -5.90 1,885.70 EUR/USD -0.0015 1.2152 JPY/USD -0.04 109.48 10-Year Note +0.019 1.579% World News The G7 reached a landmark deal on Saturday to squeeze more money out of multinational companies such as Amazon and Google and reduce their incentive to shift profits to low-tax offshore havens. Hundreds of billions of dollars could flow into the coffers of governments left cash-strapped by the COVID-19 pandemic after the Group of Seven (G7) advanced economies agreed to back a minimum global corporate tax rate of at least 15%. Treasury Secretary Janet Yellen said President Joe Biden should push forward with his $4 trillion spending plans even if they trigger inflation that persists into next year and higher interest rates. “If we ended up with a slightly higher interest rate environment it would actually be a plus for society’s point of view and the Fed’s point of view,” Yellen said Sunday in an interview with Bloomberg News Sector News Breakdown Consumer Las Vegas is making a comeback according to Barron’s saying bookings at casino resorts have gone up, but convention and expo business still faces uncertainty after the pandemic. Among REITs, MGM Growth Properties ($MGP) and VICI Properties ($VICI) offer yields above 4%. Two major Las Vegas Strip players are MGM Resorts International ($MGM) and Caesars Entertainment ($CZR). Regional casinos Boyd Gaming ($BYD) and Red Rock Resorts ($RRR), which cater more to the local market, have gained more than MGM and Caesars since the end of last January. Avis Budget Group Inc ($CAR) board approved a $325 mln increase to company’s share repurchase authorization Lordstown Motors ($RIDE) said it received a notice of delinquency for late filing from the Nasdaq Stock Market because it has yet to file its 10-Q for the quarter ended March 31 Reckitt Benckiser Group Plc agreed to sell its Chinese baby-formula business to Primavera Capital Group for $2.2 billion as the company seeks to exit from the struggling sector. Reckitt will retain an 8% stake in the unit and sees net cash proceeds of about $1.3 billion Tesla ($TSLA) CEO Elon Musk told Twitter followers that the Plaid+ trim is “canceled” as the imminent, lower-priced ‘regular’ Plaid model is “just so good.” It’s the quickest production car ever, he claimed Energy, Industrials and Materials Peabody Energy ($BTU) files to say has entered into at market issuance sales agreement to offer and sell up to 12.5 mln shares of common stock Diana Shipping Inc. ($DSX) files for mixed shelf of up to $750 mln TimkenSteel ($TMST) announced it will increase base pricing on all special bar quality products by $50 per ton Trucker rating changes at Goldman Sachs as they upgraded CH Robinson ($CHRW) to Buy from Sell with a $108 price target saying asset-based truckload sector fundamentals are very robust right now with supply tight, demand strong and prices elevated, while the firm downgraded ArcBest (ARCB) to Neutral and Werner ($WERN) to Sell Financials Barron’s said Allegiance Bancshares ($ABTX), PNC Financial Services Group ($PNC), Pinnacle Financial Partners ($PNFP), SVB Financial Group ($SIVB) are banks that operate in regions where growth is booming, and they can benefit from loan growth sooner Realty Income Corp ($O) files mixed securities shelf Essex Property ($ESS) raises low end of core FFO guidance for Q2 and FY21 as now sees Q2 core FFO of $2.92-3.00 (prior: $2.84-3.00) vs. a consensus of $2.98; sees FY21 core FFO of $12.02-12.46 (prior: $11.46-$12.46) vs. $12.23 consensus. Visa ($V) upgraded to Overweight from Neutral at Piper Sandler and up tgt to $260 from $234 Healthcare Biogen ($BIIB) rises ahead of FDA decision on Alzheimer’s drug aducanumab as the FDA is set to decide on whether to approve company’s controversial Alzheimer’s disease drug. If approved, Biogen’s aducanumab would be the first treatment in more than a decade to treat the disease (other companies with Alzheimer treatments include $AVXL, $PRTA, $SAVA) ChromaDex Corp. ($CDXC) announced the launch of its flagship consumer product Tru Niagen(R) in Walmart, available in 3,800 stores across the United States. Walmart is the first major U.S. retailer to bring this well-studied healthy aging nutrient to stores Fate Therapeutics ($FATE) upgraded to Buy from Neutral at H.C. Wainwright Liminal BioSciences ($LMNL) shares jumped post-market Friday after the U.S. FDA approved Ryplazim for the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenia) Iovance Biotherapeutics ($IOVA) announced updated clinical data for lifileucel from Cohort 2 in the C-144-01 clinical study in patients with advanced melanoma. The data were presented in an oral presentation at the ASCO 2021 Annual Meeting Novartis ($NVS) announced Phase 2 primary endpoint data showing investigational iptacopan – a first-in-class, oral, targeted factor B inhibitor – reduced protein in the urine, an increasingly recognized surrogate marker correlating with progression to kidney failure, and showed promise in stabilizing kidney function in patients with IgA nephropathy, or IgAN Technology, Media & Telecom Apple ($AAPL) will debut major software updates for the iPhone and iPad at its developers’ conference this week Software maker PTC ($PTC) is up 60% over the past two years, but it has more upside as it seeks to dominate the Internet of Things, Barron’s says. Autodesk ($ADSK) confirmed that it has submitted a non-binding proposal to acquire all the outstanding shares of common stock of Altium ($ALMFF) for A$38.50 Flextronics ($FLEX) forecasted that the chip shortage disrupting the car industry and the supply of consumer technology products will last until at least mid-2022 – Financial Times reported

52 Replies 13 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

suprised $AVXL hasnt reacted with it

54 Replies 8 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

watching $AVXL with $SAVA for a short

96 Replies 9 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

I think $AACG, $sava, $avxl, $CPSH ran much higher then they should have

108 Replies 15 👍 11 🔥

AN
@andres168 #StockTraders.NET
recently

sympathy with sava and avxl

98 Replies 12 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$AVXL no more borrows at etrade

49 Replies 6 👍 10 🔥

Key Metrics

Market Cap

1.29 B

Beta

1.77

Avg. Volume

0.91 M

Shares Outstanding

76.02 M

Yield

0%

Public Float

0

Next Earnings Date

2022-02-09

Next Dividend Date

Company Information

Anavex Life Sciences Corp. is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, Parkinson's disease, Rett syndrome and other central nervous system (CNS) diseases, pain and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), recently completed a successful Phase 2a clinical trial for Alzheimer's disease. ANAVEX®2-73 (blarcamesine) is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer's disease. ANAVEX®2-73 (blarcamesine) also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The Michael J. Fox Foundation for Parkinson's Research previously awarded Anavex a research grant, which fully funded a preclinical study to develop ANAVEX®2-73 (blarcamesine) for the treatment of Parkinson's disease. ANAVEX®3-71, which targets sigma-1 and muscarinic receptors, is a promising preclinical drug candidate demonstrating disease-modifying activity against the major hallmarks of Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies. In preclinical trials, ANAVEX®3-71 has shown beneficial effects on mitochondrial dysfunction and neuroinflammation.

CEO: Christopher Missling

Website:

HQ: 51 W 52nd St Fl 7th New York, 10019-6163 New York

Related News